Cargando…

Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis

SIMPLE SUMMARY: Metaplastic breast cancer (MpBC) is a rare disease—an aggressive subtype among breast cancers. Though there are no clear treatment guidelines, MpBC generally is treated aggressively by chemotherapy or radiation therapy because of its rarity and propensity to recur. We assessed the cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jun-Hee, Ryu, Jai Min, Lee, Se Kyung, Chae, Byung Joo, Lee, Jeong Eon, Kim, Seok Won, Nam, Seok Jin, Yu, Jonghan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000576/ https://www.ncbi.nlm.nih.gov/pubmed/36900347 http://dx.doi.org/10.3390/cancers15051556

Ejemplares similares

The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis
por: Kim, Kangpyo, et al.
Publicado: (2023)

Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence
por: Ryu, Jai Min, et al.
Publicado: (2020)

Validation of the Clinical Treatment Score Post–Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea
por: Lee, Jun-Hee, et al.
Publicado: (2021)

Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study
por: Choi, Hee Jun, et al.
Publicado: (2021)

Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm
por: Alsharif, Emad, et al.
Publicado: (2019)

Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
por: Lee, Jun-Hee, et al.
Publicado: (2022)

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Effect of Poloxamer-Based Thermo-Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial
por: Choi, Hee Jun, et al.
Publicado: (2021)

Clinicopathologic Features and Outcomes of Metaplastic Breast Carcinoma: Comparison with Invasive Ductal Carcinoma of the Breast
por: Park, Hyung Seok, et al.
Publicado: (2010)

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
por: Woo, Jinsun, et al.
Publicado: (2021)

The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer
por: Park, Woong Ki, et al.
Publicado: (2023)

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
por: Lee, Jun-Hee, et al.
Publicado: (2022)

Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?
por: Jung, Sung Mi, et al.
Publicado: (2020)

Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer
por: Min, Seung Ki, et al.
Publicado: (2021)

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience
por: Kim, Ji-Yeon, et al.
Publicado: (2022)

Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study
por: Kim, Yeon Jin, et al.
Publicado: (2023)

Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning–Based Analysis
por: Kang, Danbee, et al.
Publicado: (2023)

Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study
por: Ryu, Jai Min, et al.
Publicado: (2017)

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
por: Choi, Hee Jun, et al.
Publicado: (2019)

Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea
por: Kim, Yeon-Jin, et al.
Publicado: (2022)

Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?
por: Jung, Sung Mi, et al.
Publicado: (2021)

Male metaplastic breast cancer with poor prognosis: A case report
por: Kim, Hyun Yul, et al.
Publicado: (2022)

Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomy
por: Kim, Nalee, et al.
Publicado: (2022)

Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study
por: Kwak, Youngji, et al.
Publicado: (2023)

Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer
por: Kim, Jae-Myung, et al.
Publicado: (2018)

Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study
por: Choi, Hee Jun, et al.
Publicado: (2018)

Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma
por: Park, Inhye, et al.
Publicado: (2013)

Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
por: You, Kiho, et al.
Publicado: (2017)

The efficacy and safety of an indocyanine green−hyaluronic acid mixture (LuminoMark™) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial
por: Bang, Yoon Ju, et al.
Publicado: (2023)

Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors
por: Shim, Sungkeun, et al.
Publicado: (2022)

Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea
por: Rayzah, Musaed, et al.
Publicado: (2021)

Development of a Nomogram to Predict N2 or N3 Stage in T1–2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
por: Kim, Isaac, et al.
Publicado: (2017)

Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis
por: Bae, Soo Youn, et al.
Publicado: (2011)

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
por: Choi, Hee Jun, et al.
Publicado: (2018)

Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer
por: Kim, Nalee, et al.
Publicado: (2023)

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
por: Choi, Hee Jun, et al.
Publicado: (2023)

Conditional disease-free survival among patients with breast cancer
por: Paik, Hyun-June, et al.
Publicado: (2017)

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
por: Park, Sungmin, et al.
Publicado: (2017)

Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy
por: Kim, Isaac, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cktm2qho65vol2os4vmipg6vuv